Navidea Biopharmaceuticals, Inc. (NAVB) stock soared 25.58% in the pre-market trading session at the price of $1.11 following the regulatory approval of Lymphoaim in India. NAVB is a biopharmaceutical firm centered on the production of innovative immuno-diagnostic agents. The company is devising numerous precision-targeted
Liquidia Corporation (LQDA) stock plummeted 12.60% in the current-market trading session at the price of $5.41 after proposing a public offering of its common stock shares. LQDA is a biopharmaceutical firm that develops products using its proprietary PRINT technology. The company has devised YUTREPIA inhalation
Statera Biopharma, Inc. (STAB) stock plummeted 10.06% in the current market trading session at the price of $0.28 despite no fundamental updates. STAB Filed Form 12b-25 On 31st March 2022, STAB announced filing a Form 12b-25 with U.S. SEC. The Form has filed to extend
Axcella Health Inc. (AXLA) stock soared 18.28% in the current-market trading session at the price of $2.03 despite no fundamental updates. AXLA Q4 2021 Earnings Report On 30th March 2022, AXLA announced its financial results for the quarter and year ended 31st December 2021 and
StealthGas Inc. (GASS) stock soared 8.19% in the current-market trading session at the price of $2.44 despite no fundamental updates. GASS Q4 2021 Earnings Report On 8th March 2022, GASS announced its financial and operating results for the quarter and year ended 31st December 2021.
NextDecade Corporation (NEXT) stock soared 15.55% in the current-market trading session at the price of $6.91 following a sale and purchase deal with ENN LNG. NEXT Signed Contract with ENN LNG On 6th April 2022, NEXT announced signing a twenty-year sale and purchase deal with
Nano-X Imaging Ltd. (NNOX) stock soared 14.44% in the current-market trading session at the price of $13.87 after opening chip fabrication facility in South Korea. Nanox is an Israeli company that generates a commercial-scale digital X-ray source used for medical applications. The company’s novel
Protalix Bio Therapeutics, Inc. (PLX) stock soared 46.67% in the pre-market trading session at the price of $1.54 after reporting topline data from the BALANCE clinical trial evaluating PRX–102. PLX is a biopharmaceutical firm that develops and commercializes therapeutic proteins using its plant cell-based ProCellEx
Sharecare, Inc. (SHCR) stock plummeted 18.33% in the current-market trading session at the price of $2.70 after reporting its earnings report for the fourth quarter and year 2021. SHCR is the leader in digital health that enables individuals to manage and track their health on
MicroVision, Inc. (MVIS) stock soared 29.55% in the current-market trading session at the price of $5.43 despite no fundamental updates. The last reported news was its financial results for the fourth quarter and year 2021. MVIS is a pioneering firm that operates on MEMS-based laser
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.